Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2019

Open Access 01-05-2019 | Chronic Kidney Disease | Correction

Correction to: Clinical epidemiology of infectious disease among patients with chronic kidney disease

Authors: Junichi Ishigami, Kunihiro Matsushita

Published in: Clinical and Experimental Nephrology | Issue 5/2019

Login to get access

Excerpt

The article “Clinical epidemiology of infectious disease among patients with chronic kidney disease”, written by Junichi Ishigami and Kunihiro Matsushita, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 3rd September 2018 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 19th February 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​),which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. …
Metadata
Title
Correction to: Clinical epidemiology of infectious disease among patients with chronic kidney disease
Authors
Junichi Ishigami
Kunihiro Matsushita
Publication date
01-05-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 5/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01708-7

Other articles of this Issue 5/2019

Clinical and Experimental Nephrology 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine